DGCR8 C-terminal Polyclonal antibody proteintech 10996-1-AP

$449.00
In stock
SKU
10996-1-AP

 

DGCR8, C22orf12, DGCRK6, Gy1, LP4941

Host / Isotype: Rabbit / IgG Class: Polyclonal
Reactivity: Human, Mouse And More (1) Immunogen: CatNo: Ag1429 Product name: Recombinant human DGCR8 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 167-517 aa of BC009323 Sequence: VKAKVEVCKDESVDLEEFRSYLEKRFDFEQVTVKKFRTWAERRQFNREMKRKQAESERPILPANQKLITLSVQDAPTKKEFVINPNGKSEVCILHEYMQRVLKVRPVYNFFECENPSEPFGASVTIDGVTYGSGTASSKKLAKNKAARATLEILIPDFVKQTSEEKPKDSEELEYFNHISIEDSRVYELTSKAGLLSPYQILHECLKRNHGMGDTSIKFEVVPGKNQKSEYVMACGKHTVRGWCKNKRVGKQLASQKILQLLHPHVKNWGSLLRMYGRESSKMVKQETSDKSVIELQQYAKKNKPNLHILSKLQEEMKRLAEEREETRKKPKMSIVASAQPGGEPLCTVDV Predict reactive species
 Applications: WB, IHC, IF/ICC, FC (Intra), IP, CoIP, ChIP, RIP, ELISA Observed Molecular Weight: 773 aa, 86 kDa
Formulation: PBS, Azide, Glycerol GenBank Accession Number: BC009323
Conjugate: Unconjugated Gene Symbol: DGCR8
Tested Applications: Positive WB detected in Gene ID (NCBI): 54487
Application: Western Blot (WB) RRID: AB_2090987
Dilution: WB : 1:500-1:2000 Conjugate: Unconjugated
Tested Reactivity: Human, Mouse Form: Liquid
Host / Isotype: Rabbit / IgG Background Information: DGCR8 is a RNA-binding protein that assists the Rnase III enzyme Drosha in the processing of microRNAs (miRNAs), which regulate the expression of a large number of protein-coding genes[PMID: 22580560]. DGCR8, which contains two double-stranded RNA (dsRNA)-binding domains, may be an essential component of the primary miRNAs processing complex, along with Drosha, promoting the processing of primary microRNA to precursor microRNA. It is ubiquitous expressed in human and mouse tissues, and is deleted in DiGeorge syndrome[22323604]. The calculated molecular weight of DGCR8 is 82-86 kDa, but the post-modified DGCR8 is about 120 kDa (PMID: 18469815).

 

 

Reviews

Write Your Own Review
You're reviewing:DGCR8 C-terminal Polyclonal antibody proteintech 10996-1-AP
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.